Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Pilz, S; Meinitzer, A; Gaksch, M; Grübler, M; Verheyen, N; Drechsler, C; Hartaigh, BÓ; Lang, F; Alesutan, I; Voelkl, J; März, W; Tomaschitz, A.
Homoarginine in the renal and cardiovascular systems.
Amino Acids. 2015; 47(9):1703-13
Doi: 10.1007/s00726-015-1993-2
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Pilz Stefan
- Co-Autor*innen der Med Uni Graz
- Grübler Martin
- Keppel Martin Helmut
- März Winfried
- Meinitzer Andreas
- Tomaschitz Andreas
- Verheyen Nicolas Dominik
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Homoarginine (hArg) is an endogenous, nonproteinogenic amino acid which differs from arginine by an additional methylene (CH2) group in the backbone. In this brief narrative review, we summarize the current literature on hArg in the renal and cardiovascular systems. Epidemiological studies have identified low hArg levels as an independent risk marker for cardiovascular, cerebrovascular, and renal diseases as well as for mortality. The relatively low correlation of hArg with established cardiovascular risk factors underlines its great potential as an emerging biomarker to improve risk prediction because plasma hArg concentrations might reflect previously unrecognized pathophysiological processes. hArg may be involved in the pathogenesis of various diseases due to its effects on nitric oxide (NO) and energy metabolism. In view of its structural similarities with arginine, it has been proposed that hArg impacts on arginine metabolism and subsequently also on NO synthesis. The key enzyme for hArg synthesis, arginine:glycine amidinotransferase (AGAT), is involved in the synthesis of energy metabolites including guanidinoacetate, the precursor of creatine. Therefore, the involvement of hArg in energy metabolism could partially explain the close association between hArg and cardiovascular diseases such as heart failure. Whether hArg supplementation or modification of key enzymes of hArg metabolism such as AGAT activity is effective for the treatment of chronic diseases remains to be elucidated.
- Find related publications in this database (using NLM MeSH Indexing)
- Amidinotransferases - metabolism
- Animals - administration & dosage
- Biomarkers - blood
- Cerebrovascular Disorders - blood, mortality
- Energy Metabolism - administration & dosage
- Glycine - analogs & derivatives, blood
- Heart Failure - blood, mortality
- Homoarginine - blood
- Humans - administration & dosage
- Kidney Diseases - blood, mortality
- Nitric Oxide - blood
- Find related publications in this database (Keywords)
- Homoarginine
- AGAT
- Cardiovascular
- Stroke
- Heart failure
- Nitric oxide
- Mortality